[CAS NO. 436133-68-5]  Kobe0065

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [436133-68-5]

Store
Catalog
SLK-S8303
Brand
Selleck
CAS
436133-68-5

DESCRIPTION [436133-68-5]

Overview

MDL-
Molecular Weight449.79
Molecular FormulaC15H11ClF3N5O4S
SMILES-

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM2.2233 mL11.1163 mL22.2326 mL
5 mM0.4447 mL2.2233 mL4.4465 mL
10 mM0.2223 mL1.1116 mL2.2233 mL
50 mM0.0445 mL0.2223 mL0.4447 mL

Description

Kobe0065 is interaction inhibitor, exhibiting potent activity to competitively inhibit the binding of H-Ras·GTP to c-Raf-1 RBD with a Ki value of 46 ± 13 μM.

Targets

H-Ras-cRaf1 interaction [1]

In vitro

Kobe0065-family compounds bind to Ras⋅GTP and exhibit antiproliferative activity toward cancer cells carrying the activated ras oncogenes. The compounds efficiently inhibit the interaction of Ras⋅GTP with their multiple effectors including Raf, PI3K, and RalGDS and a regulator/effector Sos and show rather broad binding specificity toward various Ras family small GTPases, which may account for their higher potency at the cellular level compared with that of the in vitro binding inhibition.

In vivo

Kobe0065 has antitumor activity. The compound-treated tumors show a prominent increase of apoptotic cells without any significant body weight loss.